LUPANETA PACK Drug Patent Profile
✉ Email this page to a colleague
When do Lupaneta Pack patents expire, and when can generic versions of Lupaneta Pack launch?
Lupaneta Pack is a drug marketed by Abbvie Endocrine and is included in one NDA.
The generic ingredient in LUPANETA PACK is leuprolide acetate; norethindrone acetate. There are twenty-two drug master file entries for this compound. Additional details are available on the leuprolide acetate; norethindrone acetate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LUPANETA PACK?
- What are the global sales for LUPANETA PACK?
- What is Average Wholesale Price for LUPANETA PACK?
Summary for LUPANETA PACK
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 1 |
Patent Applications: | 1 |
What excipients (inactive ingredients) are in LUPANETA PACK? | LUPANETA PACK excipients list |
DailyMed Link: | LUPANETA PACK at DailyMed |
US Patents and Regulatory Information for LUPANETA PACK
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie Endocrine | LUPANETA PACK | leuprolide acetate; norethindrone acetate | INJECTABLE, TABLET;INTRAMUSCULAR, ORAL | 203696-001 | Dec 14, 2012 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Abbvie Endocrine | LUPANETA PACK | leuprolide acetate; norethindrone acetate | INJECTABLE, TABLET;INTRAMUSCULAR, ORAL | 203696-002 | Dec 14, 2012 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LUPANETA PACK
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie Endocrine | LUPANETA PACK | leuprolide acetate; norethindrone acetate | INJECTABLE, TABLET;INTRAMUSCULAR, ORAL | 203696-001 | Dec 14, 2012 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie Endocrine | LUPANETA PACK | leuprolide acetate; norethindrone acetate | INJECTABLE, TABLET;INTRAMUSCULAR, ORAL | 203696-002 | Dec 14, 2012 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LUPANETA PACK
See the table below for patents covering LUPANETA PACK around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | 2008291041 | PRODUCTION METHOD OF MICROSPHERE | ⤷ Sign Up |
Japan | 3191004 | ⤷ Sign Up | |
Japan | 2001252552 | METHOD FOR PRODUCING MICROSPHERE | ⤷ Sign Up |
Denmark | 1142567 | ⤷ Sign Up | |
Spain | 2249362 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |